Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/17/2025

Low Blood Levels of Arachidonic and Linoleic Acids: Clinical Significance

Essential Fatty Acid Status and Requirements

  • Linoleic acid is one of only two truly essential fatty acids for humans, while arachidonic acid is classified as conditionally essential, according to the Clinical Nutrition guideline 1
  • With adequate fat intake, normal essential fatty acid status is maintained even with relatively low omega-6 consumption, as stated by the Genetics in Medicine guideline 2, 3
  • Essential fatty acid deficiency can be determined by measuring linoleic acid levels or the triene:tetraene ratio, as recommended by the Clinical Nutrition guideline 1

Cardiovascular and Metabolic Implications

  • Individuals with genetically very low LDL-cholesterol demonstrate lower rates of cardiovascular events with no observed plateau in benefit, even at LDL-C levels as low as 10 mg/dL, according to the American College of Cardiology guideline, as summarized by Praxis Medical Insights 4
  • Higher dietary LA intake shows mixed evidence for cardiovascular benefit, with some meta-analyses showing modest CHD risk reduction while others show no clear benefit, as reported by the Advances in Nutrition guideline 5, 6

High-Risk Populations

  • Patients with fat malabsorption syndromes, such as cystic fibrosis, require monitoring for essential fatty acid deficiency, as stated by the Clinical Nutrition guideline 1, 7
  • Individuals on severely fat-restricted diets or fat-free medical foods may require supplementation, according to the Genetics in Medicine guideline 2, 3

Clinical Manifestations of True Deficiency

  • Low LA levels correlate with poor pulmonary status and impaired growth in children with cystic fibrosis, as reported by the Clinical Nutrition guideline 1
  • Impaired bone mineral density is observed when low LA levels are combined with low DHA and high AA:DHA ratio, according to the Clinical Nutrition guideline 1

Practical Management Approach

  • No intervention is typically needed for healthy adults with low levels if they are asymptomatic and have no signs of essential fatty acid deficiency, as stated by the Genetics in Medicine guideline 2
  • Supplementation should only be considered if diet contains inadequate sources of LA and alpha-linolenic acid, or if clinical signs of essential fatty acid deficiency are present, according to the Genetics in Medicine guideline 2, 3

Monitoring Strategy

  • Measure linoleic acid levels or T3:T4 ratio to monitor for deficiency, as recommended by the Clinical Nutrition guideline 1
  • Assess for clinical signs, such as dermatitis, poor growth, and impaired wound healing, according to the Clinical Nutrition guideline 1